VAERS reports by lot

Merck HPV lot L026602: VAERS reports

62 VAERS reports list lot L026602 as a Merck HPV vaccine, received between 2016-03-03 and 2019-11-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
62
Reports
16%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological2924%
General / Systemic (non-local)2823%
Injection-site / Local reaction2117%
Gastrointestinal1714%
Musculoskeletal97%
Cardiac / Cardiovascular54%
Allergic / Anaphylactic54%
Respiratory32%
Reproductive / Menstrual32%
Dermatological (non-injection-site)22%

Where reports came from

U.S. state of the reporter, where given (top 12).

Utah17
California6
Colorado2
Massachusetts2
Indiana2
West Virginia1
Michigan1
Montana1
New Jersey1
Texas1
Maryland1
North Carolina1

Reports by month received

2016-031
2016-045
2016-054
2016-065
2016-074
2016-084
2016-0924
2016-103
2016-111
2016-123
2017-032
2017-053
2017-061
2019-031
2019-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.